ESC Premium Access

The predictors and risk factors of atrial fibrillation in a population cohort and its association with valvular heart disease

Congress Presentation

About the speaker

Associate Professor Syed Khurram Mushtaq Gardezi

Guy's and St Thomas' NHS Trust Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)
0 follower

9 more presentations in this session

Dabigatran improves antibiotic efficacy in experimental Staphylococcus aureus endocarditis

Speaker: Doctor C. Lerche (Copenhagen, DK)


High-molecular-weight von Willebrand factor multimer ratio for the differentiation between true-severe and pseudo-severe low-flow, low-gradient aortic stenosis

Speaker: Doctor J. Kellermair (Linz, AT)


Impact of on-clopidogrel platelet reactivity on incidence of hypo-attenuated leaflet thickening after transcatheter aortic valve implantation

Speaker: Doctor T. Nuehrenberg (Bad Krozingen, DE)


Time in therapeutic range and risk of thromboembolism and bleeding in patients with mechanical heart valve prosthesis

Speaker: Doctor E. Havers-Borgersen (Copenhagen, DK)


Is long-term oral anticoagulation plus an antiplatelet drug better than anticoagulants alone after concomitant heart valve replacement and coronary artery bypass surgery?

Speaker: Doctor I. Cho (Seoul, KR)


Access the full session

Poster Session 5 - Thrombosis and antithrombotic treatment in valvular heart disease

Speakers: Associate Professor S. Gardezi, Doctor C. Lerche, Doctor J. Kellermair, Doctor T. Nuehrenberg, Doctor E. Havers-Borgersen...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb